Basics Monte Rosa Therapeutics, Inc. IPO Date: June 24, 2021 Sector: Healthcare Industry: Biotech Market Cap: $305.09M Activated in VL: True Average Daily Range Avg Daily Range: $0.39 | 4.18% Avg Daily Range (30 D): $0.15 | 3.02% Avg Daily Range (90 D): $0.14 | 2.95% Institutional Daily Volume Avg Daily Volume: .34M Avg Daily Volume (30 D): .34M Avg Daily Volume (90 D): .36M Trade Size Avg Trade Size (Sh.): 88 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 77 Institutional Trades Total Inst.Trades: 232 Avg Inst. Trade: $2.71M Avg Inst. Trade (30 D): $.63M Avg Inst. Trade (90 D): $.89M Avg Inst. Trade Volume: .29M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $2.8M Avg Closing Trade (30 D): $.63M Avg Closing Trade (90 D): $.92M Avg Closing Volume: 248.55K     News Jul 21, 2025 @ 11:00 AM Monte Rosa Therapeutics Announces First Subjects D... Source: Monte Rosa Therapeutics Jul 3, 2025 @ 6:15 PM Monte Rosa Announces Publication in Science of Key... Source: Monte Rosa Therapeutics Jun 10, 2025 @ 11:00 AM Monte Rosa Therapeutics Announces FDA Clearance of... Source: N/A Apr 28, 2025 @ 11:00 AM Monte Rosa Therapeutics Presents Preclinical Data ... Source: N/A Jan 6, 2025 @ 12:00 PM Monte Rosa Therapeutics to Present at the 43rd Ann... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS Diluted EPS Revenue $ 177.99M $ 23.19M $ 84.93M Gross Profit $ $ $ Net Income / Loss $ 24.17M $ -12.3M $ 46.89M Operating Income / Loss $ 14.96M $ -15.55M $ 44.04M Cost of Revenue $ $ $ Net Cash Flow $ -39.33M $ -9.03M $ -145.71M PE Ratio